PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24098639-0	2013	New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles.	Chlorambucil	82-94	keratin 20	Homo sapiens	126-130	
24098639-3	2013	In this contribution, we propose a novel therapeutic approach in which relatively high doses of Hydroxychloroquine and Chlorambucil were loaded into biodegradable nanoparticles coated with an anti-CD20 antibody.	Chlorambucil	119-131	keratin 20	Homo sapiens	197-201	
24098639-8	2013	In vitro and in vivo data showed the ability of anti-CD20 nanoparticles loaded with Hydroxychloroquine and Chlorambucil to increase tumor cell killing in comparison to free cytotoxic agents or Rituximab.	Chlorambucil	107-119	keratin 20	Homo sapiens	53-57	
24098639-9	2013	These results shed light on the potential of anti-CD20 nanoparticles carrying Hydroxychloroquine and Chlorambucil for controlling a disseminated model of aggressive lymphoma, and lend credence to the idea of adopting this therapeutic approach for the treatment of B-cell disorders.	Chlorambucil	101-113	keratin 20	Homo sapiens	50-54